MR. RONALD EARL REECE MD NPI 1144288523

NPI Details

MR. Ronald Earl Reece, MD is a dermatology in Redding, CA with 46 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. MR. Ronald Earl Reece, MD NPI is 1144288523. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1980

The provider's business location address is:

2701 OLD EUREKA WAY
SUITE 2A
REDDING, CA
ZIP 96001-226
Phone: (530) 246-0236
Fax: (530) 246-0276

The NPI 1144288523 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D0693457 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Test for allergy using skin patch (HCPCS:95044)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Punch biopsy, first skin growth (HCPCS:11104)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Application of vein wound compression bandages on lower leg, ankle, and foot (HCPCS:29581)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Punch biopsy, each additional skin growth (HCPCS:11105)
• Removal of inflamed or infected skin, up to 10% of body surface (HCPCS:11000)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Application of light with debridement to destroy precancer skin growth (HCPCS:96574)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11601)
• Fungal culture (mold or yeast) of skin, hair, or nail (HCPCS:87101)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11641)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Removal of noncancer skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11401)
• Tissue fungi or parasites (HCPCS:87220)
• Biopsy of ear (HCPCS:69100)
• Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11621)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:11421)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11441)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Complicated or multiple drainage of skin abscess (HCPCS:10061)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11440)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11640)
• Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm (HCPCS:12052)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 5/3/2006 and was last updated on 8/12/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.